Systematic Alpha Investments’s DexCom DXCM Stock Holding History

Systematic Alpha Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,172	Closed	-$246K	–	228
2024 Q2	$246K	Hold	2,172	–	–	0.01%	199
2024 Q1	$301K	Hold	2,172	–	–	0.01%	188
2023 Q4	$270K	Hold	2,172	–	–	0.01%	193
2023 Q3	$203K	Hold	2,172	–	–	0.01%	203
2023 Q2	$279K	Hold	2,172	–	–	0.01%	186
2023 Q1	$252K	Hold	2,172	–	–	0.01%	193
2022 Q4	$246K	Buy	+2,172	New	+$238K	0.01%	199
2022 Q2	–	Sell	-2,172	Closed	-$278K	–	214
2022 Q1	$278K	Hold	2,172	–	–	0.01%	204
2021 Q4	$292K	Hold	2,172	–	–	0.01%	198
2021 Q3	$338K	Hold	2,172	–	–	0.01%	194
2021 Q2	$271K	Buy	+2,172	New	+$209K	0.01%	174

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Systematic Alpha Investments's DXCM Position: Q3 2024 in Review

Systematic Alpha Investments sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,172 shares — an estimated $246K sold.

Systematic Alpha Investments first reported a position in DXCM in Q2 2021 and held it in 11 quarters. The position peaked at $338K in Q3 2021. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Systematic Alpha Investments reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Systematic Alpha Investments sold 2,172 DexCom shares in Q3 2024, an estimated $246K.
Systematic Alpha Investments first reported a position in DexCom in Q2 2021 and held it in 11 quarters.
Systematic Alpha Investments's DexCom position peaked at $338K in Q3 2021.
889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Systematic Alpha Investments's 13F filing for Q3 2024, filed 13 Nov 2024.